tirzepatide triple agonist First-in-Class 'Triple-G'! Retatrutide, a first-in-class GIP, GLP-1 & Glucagon hormone receptor drug leads to nearly 29% weight loss in first pivotal test! Eli Lilly announced positive topline results from the Retatrutide vs Tirzepatide: Triple Agonist
Pay in 4 interest-free payments of $6.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27












:max_bytes(150000):strip_icc()/Wegovy-pill-pic-590ed53ed3304ba8b2388f9d78886dae.png)





:max_bytes(150000):strip_icc():focal(749x0:751x2)/gpl-1-jabs-052226-1-010a064224da4f85bf4c6ea0952739c8.jpg)


-(1).png?sfvrsn=c236e848_3)




